TY  - GEN
AU  - Grasselli, J
AU  - Elez, Elena
AU  - Caratu, G
AU  - Matito, J
AU  - Santos, C
AU  - Macarulla, T
AU  - Vidal, J
AU  - Garcia, M
AU  - Vieitez, J. M
AU  - Paez, D
AU  - Falcó, Esther
AU  - Lopez Lopez, C
AU  - Aranda, E
AU  - Jones, F
AU  - Sikri, V
AU  - Nuciforo, P
AU  - Fasani, Roberta
AU  - Tabernero, J
AU  - Montagut, C
AU  - Azuara, D
AU  - Dienstmann, R
AU  - Salazar, R
AU  - Vivancos, A
PY  - 2017
DO  - 10.1093/annonc/mdx112
SN  - 0923-7534
UR  - http://hdl.handle.net/20.500.12105/20432
AB  - Background: Circulating tumor DNA (ctDNA) is a potential source for tumor genome analysis. We explored the concordance between the mutational status of RAS in tumor tissue and ctDNA in metastatic colorectal cancer (mCRC) patients to establish...
LA  - eng
PB  - Oxford University Press
KW  - anti-EGFR therapy
KW  - Circulating tumor DNA
KW  - Metastatic colorectal cancer
KW  - RAS analysis
KW  - Mutation
KW  - Neoplasm Metastasis
KW  - Colorectal Neoplasms
KW  - Humans
KW  - ErbB Receptors
KW  - Genes, ras
TI  - Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer
TY  - research article
ER  -